Publication | Open Access

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

ImmunogeneticsSystems BiologyDistinct Therapeutic VulnerabilitiesAutoimmune DiseaseTranscription Factor ProgramsMedicineImmunologyImmunologic MechanismAutoimmunityImmune Pathway ActivationImmunopathologyTranscription FactorsImmunotherapyImmune Dysregulation